DBS: China Biotech Sector
https://alphaedgeinvesting.com/2022/07/01/dbs-china-biotech-sector/
$BEIGENE(06160.HK$ $CSPC PHARMA(01093.HK$ $HENLIUS(02696.HK$ $MICROPORT(00853.HK$ $WEIGAO GROUP(01066.HK$ $SINOPHARM(01099.HK$ $CR MEDICAL(01515.HK$ $CONSUN PHARMA(01681.HK$ $CHUNLI MEDICAL(01858.HK$ $UNI MEDICAL(02666.HK$ $HENLIUS(02696.HK$ $B-Soft Co.,Ltd.(300451.SZ$ $Guangxi LiuYao Group(603368.SH$ $BEIGENE(06160.HK$
$BEIGENE(06160.HK$ $CSPC PHARMA(01093.HK$ $HENLIUS(02696.HK$ $MICROPORT(00853.HK$ $WEIGAO GROUP(01066.HK$ $SINOPHARM(01099.HK$ $CR MEDICAL(01515.HK$ $CONSUN PHARMA(01681.HK$ $CHUNLI MEDICAL(01858.HK$ $UNI MEDICAL(02666.HK$ $HENLIUS(02696.HK$ $B-Soft Co.,Ltd.(300451.SZ$ $Guangxi LiuYao Group(603368.SH$ $BEIGENE(06160.HK$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment